Drug Kinetics – News and Features

Under the terms of this agreement, Mochida will receive a multi-user license to Admensa Interactive.

Bio-Rad's KnowItAll Informatics System offers a complete suite of tools for the computer-based prediction of a potential drug's ADME/Tox profile.

The agreement provides Angiotech with immediate access to CombinatoRx's combination pharmaceutical compounds.

The Alliance targets on developing RNAi-based therapeutics against select gene targets in ophthalmic diseases.

This collaboration allows Elan to access Strand's technologies and achieve customized solutions for internal research programs.

After 11 years as The Society for Biomolecular Screening, members have voted and approved the new name “Society for Biomolecular Sciences.”

InforSense KDE, will provide Bayer with a flexible rapid application development platform to optimize their drug discovery decision-making.

InforSense KDE, will provide Bayer with a flexible rapid application development platform to optimize their drug discovery decision-making.

Admetis has an extensive data mining and visualization module that is designed to support an embedded chemical structure viewer.

Organon elected to continue the collaboration by accepting the latest preclinical lead candidate generated by Pharmacopeia's drug discovery and development platform.